AHL and AI-2 bioreporter assays.

JR Jeremy T. Ritzert
GM George Minasov
RE Ryan Embry
MS Matthew J. Schipma
KS Karla J. F. Satchell
request Request a Protocol
ask Ask a question
Favorite

R. radiobacter carrying pZLR4 was grown overnight at 30°C. Cultures were diluted to an OD620 of 0.1 in 1 ml of BHI medium. A 1-μl volume of filter-sterilized supernatants of Y. pestis or 10 μl of filter-sterilized BALF, previously collected from mice intranasally infected with wild-type Y. pestis (26), was added. Tubes were incubated at 30°C with shaking at 250 rpm for 5 h. Cultures were pelleted and resuspended in 500 μl of Z-buffer (60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1 mM MgSO4, pH 7.0). A 25-μl volume of chloroform and a 12.5-μl volume of 0.1% SDS were used to lyse the bacteria for 5 min. A 100-μl volume of 2-nitrophenyl-β-d-galactopyranoside (ONPG; 4 mg/ml) was added to initiate the galactosidase reaction, which was stopped by the addition of 250 μl of 1 M Na2CO3. The reaction mixtures were centrifuged for 5 min at 13,000 rpm, and 500 μl was added to a cuvette to record the OD420. Relative beta-galactosidase activity levels were expressed as ratios of OD420/OD620.

For TLC, 100-μl volumes of culture supernatants or BALF were extracted twice with 100 μl of ethyl acetate and concentrated to 20 μl in a 60-Hz Savant SpeedVac DNA 100 concentrator (Thermo Fisher Scientific). Volumes of 1 μl of culture supernatants or 7.5 μl of BALF samples were spotted onto aluminum-backed C18-W silica plates (Sorbent Technologies) and developed in 60% methanol–40% water as described previously (55).

To measure AI-2 concentrations, overnight cultures of MM32 were diluted 1:500 and grown at 30°C for 1 h. A 180-μl volume was added to a 96-well plate with 20 μl of either culture supernatant or BALF. Plates were incubated at 30°C with shaking for 5 h. Optical density and luminescence were recorded on a Molecular Devices Spectramax M5 microplate reader. Reported data are from 3 h of incubation (culture supernatants) and 4 h of incubation (BALF).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A